XML 15 R3.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 10,177,099 $ 3,237,106
Accounts receivable, net 91,277 261,809
Deferred contract costs 157,300
Other current assets 476,004 729,342
Current assets held for sale 118,459
Total current assets 10,901,680 4,346,716
Other Assets 250,383
Intangible Assets, net 327,001 566,259
Goodwill 4,183,232 4,183,232
Non-current assets held for sale 27,595
Total assets 15,411,913 9,374,185
Current Liabilities:    
Accounts payable and accrued expenses 1,408,965 1,154,072
Deferred revenue 131,628 81,318
Deferred contract liability 124,150
Current liabilities held for sale 13,759
Total current liabilities 1,664,743 1,249,149
Non-current Liabilities:    
Convertible debt, net 224,424 7,841,500
Deferred Severance 325,000
Total liabilities 2,214,167 9,090,649
Commitments and Contingencies (Note 12)
Stockholders’ Equity:    
Common stock, $0.0001 par value, 250,000,000 shares authorized; 9,450,220 and 3,179,789 shares issued and outstanding as of December 31, 2023 and 2022, respectively 945 318
Additional paid in capital 172,714,712 140,257,448
Accumulated deficit (159,530,535) (140,130,159)
Accumulated comprehensive income 12,624 155,929
Total stockholders’ equity 13,197,746 283,536
Total liabilities and stockholders’ equity $ 15,411,913 $ 9,374,185